Does OFATUMUMAB Cause Flushing? 165 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 165 reports of Flushing have been filed in association with OFATUMUMAB (ARZERRA). This represents 0.6% of all adverse event reports for OFATUMUMAB.
165
Reports of Flushing with OFATUMUMAB
0.6%
of all OFATUMUMAB reports
0
Deaths
9
Hospitalizations
How Dangerous Is Flushing From OFATUMUMAB?
Of the 165 reports, 9 (5.5%) required hospitalization, and 3 (1.8%) were considered life-threatening.
Is Flushing Listed in the Official Label?
Yes, Flushing is listed as a known adverse reaction in the official FDA drug label for OFATUMUMAB.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Flushing?
DIMETHYL (10,681)
TREPROSTINIL (3,166)
TECFIDERA (2,385)
AMBRISENTAN (1,741)
DALFAMPRIDINE (1,605)
DIROXIMEL (1,518)
INFLIXIMAB (1,488)
PACLITAXEL (1,397)
GLATIRAMER (1,291)
EPOPROSTENOL (1,256)
Which OFATUMUMAB Alternatives Have Lower Flushing Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB